REGENXBIO

1 follower


REGENXBIO is seeking to improve lives through the curative potential of gene therapy. Our NAV® Technology Platform has ushered in a new era of gene therapy innovation.

Industries

Headquarters

Stage

Employees

Links

Ken Mills
President & CEO

Ken Mills

Collapse
Curran M. Simpson
Chief Operating Officer
Steve Pakola
Chief Medical Officer
Olivier Danos
Chief Scientific Officer
Shiva G. Fritsch
Chief Communications & People Officer
Patrick J. Christmas II
Chief Legal Officer
Laura Coruzzi
EVP, Intellectual Property
Ram Palanki
EVP, Commercial Strategy & Operations